Jonathan P. Biller sells shares; Vertex Pharmaceuticals (NASDAQ: VRTX) Form 144
Rhea-AI Filing Summary
Jonathan P. Biller reported sales of Common stock under Rule 144. The filing lists sales of
The form also shows a Restricted Stock Vesting entry dated
Positive
- None.
Negative
- None.
Insights
Routine insider sales disclosed under Rule 144; amounts and dates are explicit.
The filing records multiple open-market dispositions by Jonathan P. Biller, with aggregate proceeds visible across four dated entries. Each sale line lists the share count and corresponding dollar proceeds, providing a clear transaction record.
These are disclosed sales activity; their investment impact depends on total holdings and timing not shown here. Subsequent filings or company disclosures would be needed to assess any change in beneficial ownership.
Restricted stock vesting item is noted, tied to compensation on
The excerpt includes a "Restricted Stock Vesting" entry dated
Timing and whether vested shares were sold or retained are not detailed beyond the listed sale lines; further filings would clarify cash‑flow treatment and post‑vesting ownership.